The syringe redesign will first be available with select Belotero products in Europe before a phased international launch.
Merz Aesthetics announced the launch of a new syringe for its hyaluronic acid (HA) brand Belotero. The new syringe is ergonomically engineered to elevate the treatment experience, offering greater precision, comfort, and ease of use. The new syringe will launch first in Europe and then will expand to markets worldwide.
“As the first region to introduce this innovation ahead of our global expansion, I’m proud to share this exciting milestone in Belotero’s history as a trusted leader in hyaluronic acid treatments,” says Gonzalo Mibelli, president EMEA region, in a release.
Belotero is a biomimetic HA treatment with a cohesive polydensified matrix gel, designed to mimic characteristics and behavior of the skin and deep layers. The brand features a portfolio with solutions to enhance facial features, improve skin quality, and reduce signs of aging. Belotero recently marked 20 years in the aesthetics market, with over 18 million syringes sold worldwide, according to a release from the company.
“From a design perspective, the new Belotero syringe delivers both aesthetics and functionality, particularly with its excellent haptics and ergonomic finger-grip,” says Dr Tatjana Pavicic, a board-certified dermatologist in Munich, Germany, in a release. “The anti-slip, signature color-coded silicone surfaces enhance user experience, providing easy identification, practitioner comfort, and stability during procedures.”
With a patent-protected design developed exclusively for Belotero, the new premium syringe, with the same formula, features several key improvements:
- Ergonomic design: The redesigned syringe offers a more comfortable grip, making handling easier during procedures.
- Precision: Engineered for consistent syringe performance, the syringe adapts to various angles, providing greater control and stability.
- Improved safety design: An integrated Luer Lock system keeps the needle securely attached.
“We are thrilled that our new Belotero syringe has already been recognized by a panel of expert users for providing the volume control, adaptability, and consistent handling we know our customers and patients are looking for,” says Alexis Stern, global chief marketing officer at Merz Aesthetics, in a release. “In fact, 93% of users rated the new Belotero syringe as easy and intuitive.”
The new Belotero syringe will launch starting with Belotero Balance Lidocaine, Belotero Soft Lidocaine, and Belotero Intense Lidocaine in Austria, Belgium, Netherlands, Luxembourg, Germany, Italy, Switzerland, Spain, Portugal, the United Kingdom, Ireland, and Malta, followed by a phased global rollout. All Belotero products with the current syringe remain safe and effective to use as indicated, according to a release from the company.
